1. Home
  2. PRAX vs SUN Comparison

PRAX vs SUN Comparison

Compare PRAX & SUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$325.47

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Sunoco LP

SUN

Sunoco LP

HOLD

Current Price

$62.91

Market Cap

11.6B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SUN
Founded
2015
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Integrated oil Companies
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.6B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
PRAX
SUN
Price
$325.47
$62.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
6
Target Price
$572.13
$65.17
AVG Volume (30 Days)
364.5K
440.4K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
5.91%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,201,000,000.00
Revenue This Year
N/A
$67.68
Revenue Next Year
$6,395.88
$17.10
P/E Ratio
N/A
$26.93
Revenue Growth
N/A
11.05
52 Week Low
$26.70
$47.98
52 Week High
$354.87
$64.27

Technical Indicators

Market Signals
Indicator
PRAX
SUN
Relative Strength Index (RSI) 53.52 64.96
Support Level $290.36 $51.81
Resistance Level N/A N/A
Average True Range (ATR) 18.34 1.84
MACD -2.56 0.08
Stochastic Oscillator 57.24 84.40

Price Performance

Historical Comparison
PRAX
SUN

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SUN Sunoco LP

Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.

Share on Social Networks: